The epidemiology of the prostate cancer has radically changed during the last decades, with a tendency to an increasing number of diagnosis and a concomitant reduction of mortality. This is due to both the introduction and the diffusion of PSA as a screening test and the improving of imaging and the standardization of prostate biopsy. Currently, transrectal ultrasound (TRUS) represents the gold standard radiological exam for prostate imaging because of the best costs/benefits ratio. Nevertheless, it has shown to be not highly accurate (50–60 %), with a low positive predictive value (about 6 %) in the diagnosis of a prostate cancer and with a low reliability in local staging: Thus, the role of TRUS in the evaluation of the prostate in cases of a suspected prostate cancer is still under discussion.
Scattoni, V., Maccagnano, C., Roscigno, M. (2017). Prostatic Carcinoma. In P. Martino, A.B. Galosi (a cura di), Atlas of Ultrasonography in Urology, Andrology, and Nephrology (pp. 293-304). Springer International Publishing Switzerland [10.1007/978-3-319-40782-1_24].
Prostatic Carcinoma
Roscigno M.
2017
Abstract
The epidemiology of the prostate cancer has radically changed during the last decades, with a tendency to an increasing number of diagnosis and a concomitant reduction of mortality. This is due to both the introduction and the diffusion of PSA as a screening test and the improving of imaging and the standardization of prostate biopsy. Currently, transrectal ultrasound (TRUS) represents the gold standard radiological exam for prostate imaging because of the best costs/benefits ratio. Nevertheless, it has shown to be not highly accurate (50–60 %), with a low positive predictive value (about 6 %) in the diagnosis of a prostate cancer and with a low reliability in local staging: Thus, the role of TRUS in the evaluation of the prostate in cases of a suspected prostate cancer is still under discussion.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
